Eva L. Feldman
Eva L. Feldman MD PhD
Feldman is the Russell N. DeJong Professor of Neurology, Director of the A. Alfred Taubman Medical Research institute, Director of the University of Michigan Neuropathy Center, Past President of the Peripheral Nerve Society, Immediate Past President of the American Neurological Association, and serves as the Principal Investigator of the University of Michigan International Diabetic Neuropathy Consortium site. She is annually listed in Best Doctors of America and is the recipient of multiple awards for her role in clinical translational neuropathy research. She serves as the PI or Co-I on multiple basic and clinical studies aimed at understanding the pathogenesis of diabetic neuropathy, diagnosing this disorder and developing new treatments. Feldman is an established expert in the standardized protocols currently in use for characterizing neuropathy in mouse models of type 1 and type 2 diabetes and has led the neuropathy section of Diabetes Complications Consortium. Her basic investigations are paralleled with her clinical investigations into diabetic neuropathy, where she has completed similar phenotyping in man, and published novel results on the human metabolome and transcriptome in diabetic neuropathy. She also serves as the Lead Neuropathy Investigator on two NIH funded clinical trials, CACTI and SEARCH. She has received a lifetime achievement award from the American Diabetes Association for her studies on diabetic neuropathy.
